Here, we evaluated whether baseline serum leptin and adiponectin levels could predict the development of silent brain infarcts in subjects with MCI and AD from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. The gene discussed is ADIPOQ; the disease is Alzheimer disease.